BioCentury
ARTICLE | Clinical News

Atrix completes enrollment

July 19, 2000 7:00 AM UTC

ATRX said it completed enrollment earlier than expected in its double-blind, dose-ranging Phase II trial of Atrisone dapsone topical gel to treat moderate to severe acne. The company expects to begin ...